201 related articles for article (PubMed ID: 15258974)
1. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.
Walling DM; Andritsos LA; Etienne W; Payne DA; Aronson JF; Flaitz CM; Nichols CM
J Med Virol; 2004 Sep; 74(1):94-101. PubMed ID: 15258974
[TBL] [Abstract][Full Text] [Related]
2. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
3. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
[TBL] [Abstract][Full Text] [Related]
5. T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma.
Vrsalovic MM; Korac P; Dominis M; Ostojic S; Mannhalter C; Kusec R
Hematol Oncol; 2004 Dec; 22(4):169-77. PubMed ID: 16134192
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
[TBL] [Abstract][Full Text] [Related]
7. Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses.
Libra M; Gloghini A; De Re V; Rupolo M; Navolanic PM; Gasparotto D; Stivala F; Spina M; Boiocchi M; Carbone A
Int J Oncol; 2005 Apr; 26(4):945-50. PubMed ID: 15753988
[TBL] [Abstract][Full Text] [Related]
8. Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma.
Shiozawa E; Saito B; Yamochi-Onizuka T; Makino R; Takimoto M; Nakamaki T; Tomoyasu S; Ota H
Pathol Int; 2007 Oct; 57(10):688-93. PubMed ID: 17803658
[TBL] [Abstract][Full Text] [Related]
9. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
Endo R; Yoshioka M; Ebihara T; Ishiguro N; Kikuta H; Kobayashi K
Med Hypotheses; 2004; 63(4):582-7. PubMed ID: 15325000
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
11. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
Saechan V; Mori A; Mitarnun W; Settheetham-Ishida W; Ishida T
J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis reveals somatically mutated and unmutated clonal and oligoclonal B cells in T-cell-rich B-cell lymphoma.
Hodges E; Hamid Y; Quin CT; Angus B; Wilkins BS; Wright DH; Smith JL
J Pathol; 2000 Dec; 192(4):479-87. PubMed ID: 11113865
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
Capello D; Berra E; Cerri M; Gaidano G
Minerva Med; 2004 Feb; 95(1):53-64. PubMed ID: 15041926
[TBL] [Abstract][Full Text] [Related]
15. EBV-associated lymphoproliferative disorders: classification and treatment.
Carbone A; Gloghini A; Dotti G
Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
[TBL] [Abstract][Full Text] [Related]
16. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
17. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
Huang Q; Wilczynski SP; Chang KL; Weiss LM
Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
[TBL] [Abstract][Full Text] [Related]
18. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers.
Kaplan MA; Ferry JA; Harris NL; Jacobson JO
Am J Clin Pathol; 1994 May; 101(5):590-6. PubMed ID: 8178765
[TBL] [Abstract][Full Text] [Related]
19. Fatal Epstein-Barr virus-associated lymphoproliferative disorder in childhood.
Yatabe Y; Mori N; Oka K; Iijima T; Saga S; Takada K; Asai J
Arch Pathol Lab Med; 1995 May; 119(5):409-17. PubMed ID: 7748067
[TBL] [Abstract][Full Text] [Related]
20. Evolution of clonality and invasive behavior of Epstein-Barr virus immortalized lymphoblastoid cell lines in SCID mice brains.
Bashir R; Masih A; Kallweit K; Fordyce-Boyer R; Sanger W; Purtilo D
Lab Invest; 1992 Oct; 67(4):450-6. PubMed ID: 1331608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
